Main content
Characteristics of trials at sites participating in the COVID-19 Convalescent Plasma Expanded Access Program
Contributors:
Date created: | Last Updated:
: DOI | ARK
Creating DOI. Please wait...
Category: Project
Description: Included are methods and data pulled from clinical trials.gov on trials that occurred at sites participating in the 2020 Covid-19 Convalescent Plasma expanded access program sponsored by the Mayo Clinic.
Citation
Components
Source Materials
Data provided from external sources that our study design and study data collection
Data Search Code
Code used to gather data and verify site selection
Extended Methodology
Descriptive methodology as well as methodological appendices.
Study Data
Data collected and used as described in methodology
Recent Activity
OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.
Accept